Professor Anthony Scott MSc FRCP DTM&H FMedSci

Professor of Vaccine Epidemiology,Director of the Vaccine Centre,Director HPRU in Immunisation


I trained in clinical infectious diseases and epidemiology before moving to the KEMRI-Wellcome Trust Research Programme in Kilifi, Kenya in 1993. I have spent most of the last 20 years in Kenya, studying pneumococcal disease and pneumonia in children and adults, and vaccines to prevent them. I am a Wellcome Trust Senior Research Fellow in Clinical Science and I work in clinical paediatrics in Kilifi.  I joined the School in 2013 after 15 years based at Oxford University.  In addition to my research I have developed a surveillance network for invasive bacterial diseases in East Africa (Netspear) and I co-direct the Kilifi Health and Demographic Surveillance System. I work frequently with WHO and GAVI on vaccine preventable diseases and with the Ministry of Health in Kenya on the evaluation of pneumococcal vaccine.  In the UK I am a member of the Joint Committee on Vaccination and Immunisation (JCVI) and Director of the the NIHR Health Protection Research Unit in Immunisation at LSHTM which involves a portfolio of work on disease burden, vaccine effectiveness, vaccine safety, modelling, cost-effectiveness, vaccine acceptability and policy implementation in collaboration with Public Health England




I am co-director of the short course on the Epidemiological Evaluation of Vaccines and teach on the Intensive Course on Epidemiology and Medical Statistics, the MSc Epidemiology and the Diploma course in Tropical Medicine & Hygiene.


My main research interests are in child health and vaccines in East Africa. I run the Pneumcoccal Conjugate Vaccine Impact Study, an effectiveness evaluation of vaccine introduction in Kenya, and a series of associated studies of transmission and modelling of pneumococcal disease, evaluation of vaccine safety, and pathogen population structure. I work with the Program for Appropriate Technology in Health (PATH) on the clinical development of a killed whole cell pneumococcal vaccine and with the International Vaccine Access Center at Johns Hopkins School of Public Health on a multi-centre study of the aetiology of pneumonia (PERCH - Pneumonia Etiology Research for Child Health) in developing countries. More broadly, I study the epidemiology of invasive bacterial infections in children and the way that they shape childhood mortality. I am interested in how synthesis of epidemiolgocial evidence supports effective vaccine policy in the UK and how systems for synthesising and modelling epidemiological evidence can advance vaccine policy in low-income countries.

Research areas

  • Child health
  • Clinical databases
  • Diagnostics
  • Economic evaluation
  • Global Health
  • Immunisation
  • Impact evaluation
  • Surveillance
  • Vaccines


  • Bacteriology
  • Demography
  • Epidemiology
  • Immunoepidemiology
  • Vaccinology

Disease and Health Conditions

  • Infectious disease
  • Respiratory disease
  • Sepsis
  • Tuberculosis


  • Sub-Saharan Africa (developing only)


  • Kenya

Other interests

  • Adult Mortality
  • Analysis Of Longitudinal Data
  • Bacterial Infections
  • Burden Of Disease
  • Child Mortality
  • DSS
  • East Africa
  • Effectiveness Evaluations
  • Epidemiological Methods
  • Member of Vaccine Group
  • Nosocomial infections
  • Pneumococcal Disease
  • Pneumococcal Vaccines
  • Pneumonia
  • Pneumonia In Infant Children
  • Population Based Interventions
  • clinical epidemiology
Back to top